These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 10974600)

  • 21. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
    Menting JE; Honig A; Verhey FR; Hartmans M; Rozendaal N; de Vet HC; van Praag HM
    Int Clin Psychopharmacol; 1996 Sep; 11(3):165-75. PubMed ID: 8923095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
    Ramasubbu R
    J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
    Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
    Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.
    Tiller JW; Bouwer C; Behnke K
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S7-10. PubMed ID: 10361960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction.
    Philipp M; Kohnen R; Benkert O
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):149-53. PubMed ID: 8468436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moclobemide versus fluoxetine in the treatment of inpatients with major depression.
    Gattaz WF; Vogel P; Kick H; Kohnen R
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):35S-40S. PubMed ID: 7593728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR; Jann MW
    Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday.
    Rothschild AJ
    Am J Psychiatry; 1995 Oct; 152(10):1514-6. PubMed ID: 7573593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Mandrioli R; Mercolini L; Saracino MA; Raggi MA
    Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant-induced sexual dysfunction.
    Gregorian RS; Golden KA; Bahce A; Goodman C; Kwong WJ; Khan ZM
    Ann Pharmacother; 2002 Oct; 36(10):1577-89. PubMed ID: 12243609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of social phobia with antidepressants.
    Schneier FR
    J Clin Psychiatry; 2001; 62 Suppl 1():43-8; discussion 49. PubMed ID: 11206033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moclobemide discontinuation syndrome predominantly presenting with influenza-like symptoms.
    Curtin F; Berney P; Kaufmann C
    J Psychopharmacol; 2002 Sep; 16(3):271-2. PubMed ID: 12236637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
    Hayasaka Y; Purgato M; Magni LR; Ogawa Y; Takeshima N; Cipriani A; Barbui C; Leucht S; Furukawa TA
    J Affect Disord; 2015 Jul; 180():179-84. PubMed ID: 25911132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudohallucinations associated with moclobemide: a case report.
    Degner D; Kropp S; Porzig J; Grohmann R; Rüther E
    Pharmacopsychiatry; 2005 Jul; 38(4):179-81. PubMed ID: 16025422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressants in social anxiety disorder.
    Nardi AE
    Arq Neuropsiquiatr; 2001 Sep; 59(3-A):637-42. PubMed ID: 11588653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to an open trial of a second SSRI in major depression.
    Joffe RT; Levitt AJ; Sokolov ST; Young LT
    J Clin Psychiatry; 1996 Mar; 57(3):114-5. PubMed ID: 8617695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and guide to selection of selective serotonin reuptake inhibitors.
    Edwards JG; Anderson I
    Drugs; 1999 Apr; 57(4):507-33. PubMed ID: 10235690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.
    Modell JG; Katholi CR; Modell JD; DePalma RL
    Clin Pharmacol Ther; 1997 Apr; 61(4):476-87. PubMed ID: 9129565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.